Community-Based Distribution of Misoprostol for the Prevention of ...

INFORMED CONSENT (VERBAL)
(INSTRUCTIONS FOR THE INTERVIEWERS: Please read the following statement to informant before asking
any question for the interview)
(Greet the person—Hello/Salam/Aasalaamu Aleikum). My name is .........................……. I am working with
the Mayer Hashi project of EngenderHealth, an international NGO. I hope you know that a pilot project on
misoprostol use during home delivery to prevent postdelivery excessive vaginal bleeding has been
implemented at eight upazilas of Tangail District during the period of November 2008-June 2009, by
EngenderHealth in collaboration with the Directorate General of Health Services and Directorate General of
Family Planning. We are conducting a study to understand why some women have taken the misoprostol
drug immediately after delivery of their baby and why some women did not take it. Also, we would like to
know individual opinions and suggestions about the distribution and follow-up system of misoprostol tablets
use at the community levels. Findings of this study will help the government make policy decisions to reduce
maternal deaths and to achieve MDG 5 in Bangladesh.
We have collected information from the field worker’s register that indicates you have received the
misoprostol tablets but did not take three tablets immediately after delivery of your baby to prevent excessive
postdelivery vaginal bleeding. I hope you can remember it. I would like to ask you a few questions about this
issue. The interview will take around 30 to 45 minutes of your time. The risk of your participation in this study
is minimal. Your participation in this interview is completely voluntary and there is no penalty if you decide not
to participate or refuse to respond to any question; you can stop the interview at any time. You will not receive
any direct benefit or money for your participation in the interview.
The interview will be conducted in a private setting that provides auditory privacy. Your responses will be kept
confidential. We will not share your information with anyone in your community, nor will we identify you in
any way when the study findings are published. If you permit, the discussion between you and me will be tape
recorded with voices only, to help us recall what has been discussed when preparing the report. Only the
researchers will have access to your responses, which they will utilize to prepare the report.
You may ask any questions or clarifications before giving your consent for the interview. You may also contact
Dr. Halim (01712094176) or Mr. Mahboob (8112334/36) with any questions before or after the interview.
Do you have any questions? Yes _____ No_____
If you do not have any questions, do I have your permission to continue? Yes _____ No_____
Investigator’s Statement
I, the undersigned, have explained the consent form to the woman in a language she understands. She has
given her consent to conduct the interview.
__________________________________
Signature of Investigator
___________________
Date
42 Community-Based Distribution of Misoprostol for the Prevention of PPH
Mayer Hashi project